Primary Care
Ozempic Samples for Healthcare Providers
Explore medication sample resources and treatment access support for clinicians prescribing Ozempic® (semaglutide injection).
Ozempic® (semaglutide) is a GLP-1 receptor agonist indicated for adults with type 2 diabetes mellitus. It is administered as a once-weekly subcutaneous injection and may be prescribed alongside diet and exercise to improve glycemic control.
Built to help reduce friction around treatment access & patient care.
Request Ozempic® (semaglutide injection) sample support and treatment access assistance through DocUpdate Concierge.
Request Samples Through DocUpdate
DocUpdate provides free HIPAA-compliant mobile tools that move care forward.
Frequently Asked Questions About Ozempic Samples
Healthcare providers can download the DocUpdate app and submit a request through Concierge for medication sample and treatment access support.
Ozempic® is the brand name for semaglutide, a GLP-1 receptor agonist indicated for adults with type 2 diabetes mellitus.
Ozempic® may be prescribed alongside diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus.
DocUpdate is designed for licensed healthcare providers with an active NPI number, including physicians, nurse practitioners, and physician assistants.
No. DocUpdate does not dispense medications or provide direct medication fulfillment. The platform helps healthcare providers navigate medication sample support and treatment access resources through Concierge.
Yes. DocUpdate provides free HIPAA-compliant tools and support resources for healthcare providers.